Furthermore, in microarray-based datasets of gliomas, pancreatic tumors, melanomas, and gastric cancers, we identified a correlation between the poor survival rates of the four patient groups and high expression levels of COL4A1. Here, COL4A1 is linked to pancreatic neoplasm.